Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain

Anthony N van den Pol1, Michael D Robek, Prabhat K Ghosh

  • 1Department of Neurosurgery, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06520, USA. anthony.vandenpol@yale.edu

Journal of Virology
|October 27, 2006
PubMed

Insights

Cytomegalovirus (CMV) infections pose a risk to the developing brain. Interferon (IFN) treatments effectively protected developing brain cells from both mouse and human CMV, suggesting a potential therapeutic strategy.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Cytomegalovirus (CMV) is a leading cause of congenital neurological damage.
  • Previous research indicated CMV preferentially infects developing brain cells, independent of adaptive immunity.

Purpose of the Study:

  • To investigate innate antiviral defenses against mouse (m) and human (h) CMV in developing and mature brain cells.
  • To evaluate the efficacy of interferon (IFN) in protecting against CMV infection in the brain.

Main Methods:

  • Examined interferon-stimulated gene expression in response to mCMV infection in glial and neuronal cultures.
  • Treated primary brain cultures and in vivo models with various IFNs and poly(I:C) to assess protection.
  • Assessed physiological function of IFN-protected cells using patch clamp recordings.
  • Investigated hCMV infection in human brain cells with IFN and poly(I:C) treatment.

Main Results:

  • mCMV infection robustly induced interferon-stimulated genes in both developing and mature brain cells.
  • IFN treatment significantly reduced mCMV and hCMV infection and prevented virus-induced cell death in cultured brain cells.
  • IFN-protected cells maintained normal physiological function.
  • IFN administration in vivo suppressed mCMV replication in the developing brain.

Conclusions:

  • Innate immune responses, particularly interferon signaling, play a crucial role in controlling CMV infection in the brain.
  • Interferon treatment demonstrates significant potential for reducing CMV infection and associated neurological damage in the developing brain.
  • Combining IFN therapy with existing treatments may enhance protection against CMV in vulnerable populations.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...